Cannabis Bioscience International Holdings ( (CBIH) ) has released a notification of late filing.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Cannabis Bioscience International Holdings has filed a Form 12b-25, indicating a delay in submitting its Form 10-Q (Quarter Report) for the financial period ending February 28, 2025. The delay is primarily due to the inability to analyze and complete the financial information on time. The company expects to file the report within five calendar days following the prescribed due date. Financially, the company anticipates a loss from operations of approximately $114,000 for the three months ended February 28, 2025, compared to a loss of $159,971 for the same period last year. Revenues are expected to be around $22,000, with a gross profit of $2,000. The company is actively working on compliance, with the notification signed by CEO Dante Picazo.
More about Cannabis Bioscience International Holdings
Current Market Cap: $6.83M
See more data about CBIH stock on TipRanks’ Stock Analysis page.